A Single Group Study to Evaluate the Effects of a Supplement on Premenstrual Syndrome
- Conditions
- Premenstrual Syndrome
- Registration Number
- NCT06124326
- Lead Sponsor
- Rael
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria:<br><br> - Female, aged 18-40<br><br> - Self-reported moderate discomfort during menstruation related to pelvic cramps,<br> bloating, fatigue, or mood swings.<br><br> - Self-reported symptoms during their menstrual cycle with gas, heartburn, and acid<br> reflux<br><br> - Generally healthy - don't live with any uncontrolled chronic disease<br><br> - Has a menstrual cycle between 21 and 35 days in length<br><br> - Able to predict their menstrual cycle and timing of their menstruation<br><br>Exclusion Criteria:<br><br> - Any pre-existing chronic conditions that would prevent participants from adhering to<br> the protocol, including oncological and psychiatric disorders.<br><br> - Current use of any blood thinning medication<br><br> - Anyone with known severe allergic reactions.<br><br> - Women who are pregnant, breastfeeding, or attempting to become pregnant<br><br> - Unwilling to follow the study protocol.<br><br> - Anyone with a diagnosis of a condition relating to the menstrual cycle or<br> reproductive system? e.g., polycystic ovary syndrome (PCOS), premenstrual dysphoric<br> disorder (PMDD), endometriosis, etc.<br><br> - Anyone currently on hormonal birth control, or has been on hormonal birth control in<br> the last 3 months
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in pelvic cramps.;Changes in energy levels.;Changes in overall mood.;Changes in bloating.;Changes in gastrointestinal discomfort.
- Secondary Outcome Measures
Name Time Method